Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences - May 03, 2021

May 3, 2021 20:30 UTC

BRISBANE, Calif.--(BUSINESS WIRE)-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will be participating in fireside chats at the following investor conferences:

  • BofA Securities 2021 Health Care Conference
    Date: Thursday, May 13th at 1:15 p.m. Eastern Time
  • 2021 RBC Capital Markets Global Healthcare Conference
    Date: Tuesday, May 18th at 9:45 a.m. Eastern Time

For presentations that are webcast live, an access link will be available on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentations will also be available on the Sangamo Therapeutics website after the event.

About Sangamo Therapeutics

Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, cell therapy, and genome engineering. For more information about Sangamo, visit

View source version on


Investor Relations & Media Inquiries
Aron Feingold

Source: Sangamo Therapeutics, Inc.

Back to news